Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.
about
A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment OutcomeFirst case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in SurinameDiagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).Voice disorders in mucosal leishmaniasisAmerican tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics.Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.Development of a multilocus microsatellite typing approach for discriminating strains of Leishmania (Viannia) speciesInterleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.Cutaneous Manifestations of Human and Murine LeishmaniasisCD8+ T cells in situ in different clinical forms of human cutaneous leishmaniasis.Advances in the treatment of cutaneous leishmaniasis in the new world in the last ten years: a systematic literature review.Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensisAntigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease.Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania sppEpidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period.Dendritic cell profile induced by Schistosoma mansoni antigen in cutaneous leishmaniasis patients.Nutritional status in patients with cutaneous leishmaniasis and a study of the effects of zinc supplementation together with antimony treatment.Antihelminthic therapy and antimony in cutaneous leishmaniasis: a randomized, double-blind, placebo-controlled trial in patients co-infected with helminths and Leishmania braziliensis.Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteinsIL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis Infection.Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune responseEvidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans.Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis.Development of cutaneous leishmaniasis after leishmania skin test.American cutaneous and mucocutaneous leishmaniasis (tegumentary): a diagnostic challenge.Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.Hormonal and immunological mechanisms mediating sex differences in parasite infection.A proposed new clinical staging system for patients with mucosal leishmaniasis.The immunobiology of Leishmania braziliensis infection.Dermacase. Herpes simplex virus.Transforming growth factor beta as a virulence mechanism for Leishmania braziliensisEvaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru.A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity.Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern BrazilCutaneous leishmaniasis: clinical report of two cases and review of the recent literature.Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis.The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.
P2860
Q27303693-7CE800E4-0D5C-4B13-B601-8D2D7AB82DC2Q29353798-DA931D56-B339-468E-B8A0-8231A5F7717CQ30275257-DA8F7AE4-7019-43EB-8A62-319C2F5482D7Q30434344-8E415665-47D4-4BED-A75A-54DAE7CBD0B1Q31427105-3F048950-295C-4ED6-A7A7-7D0CFD914506Q33315699-F1B10E20-CD2B-4A04-83B5-7FC2962FF332Q33479906-FBC110AA-864C-4A83-AD43-953C09DC9F8CQ33633481-5D114860-52D0-4407-804D-55B73AA7775DQ33784151-13F5099C-53D3-4242-9342-F45FDE39B520Q33839048-EE8CCF9C-E28C-464A-A782-C8B9A388522EQ33926776-14D850DF-EDF0-4E81-8BC7-66BEF55E2568Q33955466-F9F6F429-F496-4EDF-818B-14322C3CF47FQ34033888-A21BA541-E88F-4CA3-B842-95C17515FAA4Q34065388-231D9327-5728-4BF2-9003-8B945E49FC34Q34121668-A9800E00-438D-4F16-BBCF-C2A5F3663651Q34189150-428E9DB8-6666-4D1A-BACA-E039754ECDB3Q34278895-CB49644C-469E-44AF-9A9E-39D20FCE8770Q34474454-121D3489-F3E4-4D73-BDD1-2C6000278AFDQ34707782-3932C746-9BA0-4E6B-8FE5-961A167F3C1BQ34776318-AB56233D-6396-432F-8991-48CD010C9E3EQ34799364-807E0EC6-C7B4-472C-9D51-EAD57A3BD5BBQ35168283-18BC0CC7-F3B6-413B-B56C-CE764026160EQ35249747-C3ABDEA9-1975-4F98-924E-17C9E513A38FQ35445608-19E4D8A3-8FDF-4401-B733-D36265BB2FC8Q35561363-3A422FD9-B37C-4DCB-ADCA-65FCD1D58269Q35581923-54D7FC81-7416-4337-B114-BBC403094B1BQ35664259-927CA53B-2CB0-4429-9DE6-25DE881876B6Q35692504-6DED1FB9-DAEC-45BF-85D2-5D5E9A84CB99Q35947292-9066772E-0128-4985-B6F5-BB1FD12C1443Q35989712-C675B444-CC24-400F-B3E7-EE0F23424AC8Q36017212-17B17C3C-6BD7-478C-938E-565D38720698Q36059130-E95A7A1D-FB93-48EF-8976-04C5E2885864Q36244600-16EC541E-E41E-4544-823F-F1A7A6292471Q36314360-D94DF9B9-DC2E-42DC-B1C9-4ADB88AD7A92Q36364671-38C1B5B9-3C60-44A0-86ED-55A44FBA73BFQ36503554-28BF4112-1248-49D3-80E3-86D41090A0A3Q36569120-566CEF47-308E-4A27-BE02-7F859285E654Q36924412-248DEB9C-3A13-43EB-B509-647A9A8FB30FQ36995009-2570C683-E311-40FD-B951-608A1BBB9D6BQ37147622-BDD745BB-0114-431F-808E-C25B7E46F158
P2860
Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@en
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@nl
type
label
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@en
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@nl
prefLabel
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@en
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@nl
P2093
P356
P1476
Epidemiology of American cutan ...... nia braziliensis braziliensis.
@en
P2093
Barretto AC
Johnson WD Jr
P356
10.1093/INFDIS/156.1.73
P407
P577
1987-07-01T00:00:00Z